Patients should be informed of the symptoms of an aortic aneurysm and dissection, including sudden, severe and constant pain in the stomach and chest or back. Symptoms usually don’t arise until after an aneurysm bursts, which is a medical emergency. If these symptoms occur, patients should seek immediate medical attention by going to an emergency department or calling 9-1-1.
You Might Also Like
- FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review
- FDA Restricts Use of Systemic Fluoroquinolones Due to Side Effects & Will Review Application of Apadaz for Pain
- Rheumatology Drug Updates: Labeling for Fluoroquinolones; FDA to Review Benzhydrocodone/Acetaminophen Combination
Also By This Author
Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.
- Heron Therapeutics Inc. News release: FDA grants priority review designation for Heron Therapeutics’ NDA for HTX-011, a non-opioid for postoperative pain management. 2018 Dec 31.
- U.S. Food and Drug Administration. Drug safety and availability: FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. 2018 Dec 20.